Skip to main content
Tay-Sachs DiseaseRare diseaseChildren's health

What this study is

Hypothesis: To characterize and describe disease progression and heterogeneity of the gangliosidosis diseases.

This research study seeks to develop a quantitative method to delineate disease progression for the gangliosidosis diseases (Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis) in order to better understand the natural history and heterogeneity of these diseases. Such a quantitative method will also be essential for evaluating any treatments that may become available in the future, such as gene therapy. The data from this study will be necessary to provide end-points for future therapies, guide medical decisions about treatment, provide objective measurement of treatment outcomes, and accurately inform parents regarding potential outcomes.

Study details

Sponsor
University of Minnesota
Conditions
Tay-Sachs Disease · Sandhoff Disease · Late Onset Tay-Sachs Disease · GM1 Gangliosidosis · GM2 Gangliosidosis
Enrolling
52 people
Starts
2010-12
Est. completion
2027-03-01
Record
View on ClinicalTrials.gov ↗